As of 2025-05-29, the Gross Margin of Heidelberg Pharma AG (HPHA.DE) is 74%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2024-11-30 | 74% |
2023-11-30 | 67% |
2022-11-30 | 74.7% |
2021-11-30 | -169.3% |
2020-11-30 | 34% |
2019-11-30 | 48.9% |
2018-11-30 | 39.8% |
2017-11-30 | 49.7% |
2016-11-30 | 40.6% |
2015-11-30 | 50.1% |